A Caveated Boost For Me-Toos And PBMs In New Net Price Competition Study

 
• By Sarah Karlin-Smith

PBMs are able to leverage brand-to-brand competition across a variety of drug classes to lower costs, but that achievement and the presence of me-too drugs is more complicated than what might on its surface look like a clear win for the US health system.

two people in business clothes engaging in a tug of war
Head-to-head brand competition can lead to savings, new study shows. • Source: Shutterstock

More from Pricing Debate

More from Market Access